Page 4 - Tyr Pharma Company News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tyr pharma company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tyr Pharma Company Today - Breaking & Trending Today

aTyr Pharma (NASDAQ:LIFE) Downgraded by StockNews.com to Sell

StockNews.com cut shares of aTyr Pharma (NASDAQ:LIFE – Free Report) from a hold rating to a sell rating in a research note issued to investors on Tuesday. Several other equities research analysts have also issued reports on LIFE. Piper Sandler upped their price target on aTyr Pharma from $9.00 to $13.00 and gave the company […] ....

United States , Paul Schimmel , Piper Sandler , Atyr Pharma Inc , Virtu Financial , Alyeska Investment Group , Tyr Pharma Company Profile , Vanguard Group Inc , Tyr Pharma , Free Report , Moderate Buy , Tyr Pharma Stock , Get Free Report , Director Paul Schimmel , Street Corp , Tyr Pharma Company , Tyr Pharma Daily ,

aTyr Pharma (NASDAQ:LIFE) Rating Lowered to Market Perform at Oppenheimer

Oppenheimer lowered shares of aTyr Pharma (NASDAQ:LIFE – Free Report) from an outperform rating to a market perform rating in a research note published on Wednesday, Marketbeat Ratings reports. Several other equities analysts have also recently commented on LIFE. StockNews.com started coverage on aTyr Pharma in a research note on Thursday, May 18th. They set […] ....

United States , Piper Sandler , Paul Schimmel , Atyr Pharma Inc , Tyr Pharma Company Profile , Squarepoint Ops , Marshall Wace , Charles Schwab Investment Management Inc , Virtu Financial , Securities Exchange Commission , Royal Bank , Tyr Pharma , Free Report , Marketbeat Ratings , Moderate Buy , Director Paul Schimmel , Exchange Commission , Street Group , Charles Schwab Investment Management , Schwab Investment Management , Tyr Pharma Company , Tyr Pharma Daily ,

aTyr Pharma (NASDAQ:LIFE) Share Price Passes Above 200 Day Moving Average of $2.19

ATyr Pharma, Inc. (NASDAQ:LIFE – Get Rating)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.19 and traded as high as $2.35. aTyr Pharma shares last traded at $2.27, with a volume of 184,838 shares traded. Analyst Ratings Changes LIFE has been […] ....

United States , Piper Sandler , Paul Schimmel , Tyr Pharma Company Profile , Securities Exchange Commission , Atyr Pharma Inc , Royal Bank , Boothbay Fund Management , York Mellon Corp , Tower Research Capital , Millennium Management , Tyr Pharma , Get Rating , Tyr Pharma Stock , Director Paul Schimmel , Exchange Commission , Fund Management , Research Capital , New York Mellon Corp , Tyr Pharma Company , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,

StockNews.com Begins Coverage on aTyr Pharma (NASDAQ:LIFE)

StockNews.com assumed coverage on shares of aTyr Pharma (NASDAQ:LIFE – Get Rating) in a report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities analysts have also weighed in on the company. Roth Capital reissued a buy rating on shares of aTyr Pharma in a report on […] ....

San Diego , United States , Roth Mkm , Piper Sandler , Paul Schimmel , Atyr Pharma Inc , Virtu Financial , Charles Schwab Investment Management Inc , Squarepoint Ops , Royal Bank , Tyr Pharma Company Profile , Securities Exchange Commission , Marshall Wace , Tyr Pharma , Get Rating , Moderate Buy , Director Paul Schimmel , Exchange Commission , Street Group , Charles Schwab Investment Management , Schwab Investment Management , Tyr Pharma Company , Xiang Lei Yang , Bruce Beutler , Tyr Pharma Daily , Atyr Pharma ,

LA Financiere DE L Echiquier Sells 38,770 Shares of NVIDIA Co. (NASDAQ:NVDA)

ATyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 299,200 shares, a decrease of 25.1% from the April 15th total of 399,500 shares. Based on an average trading volume of 560,900 shares, the short-interest ratio is […] ....

San Diego , United States , Paul Schimmel , Roth Mkm , Alyeska Investment Group , Atyr Pharma Inc , Royal Bank , Hermes Inc , Tyr Pharma Company Profile , Vr Adviser , Stonepine Capital Management , Tyr Pharma , Get Rating , Tyr Pharma Price , Director Paul Schimmel , Capital Management , Tyr Pharma Company , Xiang Lei Yang , Bruce Beutler , Tyr Pharma Daily ,